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Tuesday, February 28, 2012 435alipid order parameters due to the presence of rhodopsin were much larger in
cholesterol-containing membranes than in cholesterol-free membranes suggest-
ing strongly that the perturbation in the lipid matrix from protein insertion rea-
ches much further away from the protein. This is expected for membranes that
are stiffer due to the presence of cholesterol. The consequences of these find-
ings for lipid mediated shifts in rhodopsin function and rhodopsin-rhodopsin in-
teractions will be discussed.Platform: Cardiac Muscle: Myosin Binding
Proteins
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Cardiac Myosin Binding Protein-C Slows Cross-Bridge Kinetics and
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Bertrand C.W. Tanner1, Yuan Wang1, Jeffrey Robbins2,
Bradley M. Palmer1.
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Cardiac myosin binding protein-C (cMyBP-C) is a thick filament protein that
augments filament stiffness and modulates cardiac contractility through its
phosphorylation. We investigated the effect of cMyBP-C on myosin cross-
bridge kinetics in demembranated papillary muscle strips from non-
transgenic (NTG) and transgenic homozygous mice lacking cMyBP-C (t/t).
Both groups expressed ~100% b-myosin heavy chain isoform due to hypothy-
roidism. Sinusoidal length perturbation analysis at maximal Ca2þ-activation
(pCa 4.8 at 17 C, 0 mM Pi) showed that MgATP-dependent myosin detach-
ment rate (g) increased hyperbolically with MgATP (0.025 to 5 mM), with sat-
urating values of 2.550.2 and 3.950.2 s1 (P<0.01) for NTG and t/t,
respectively. Kinetic analysis of g vs. [MgATP] resulted in a lower [MgATP]50
for NTG than t/t (187545 vs. 361558 mM, P<0.05). As myosin attachment
time (ton) is inversely related to g, ton correspondingly decreased as [MgATP]
increased, with saturating values of 71.355.0 and 44.252.3 ms (P<0.01) for
NTG vs. t/t, respectively. At saturating MgATP, ton decreased as [Pi] increased
in both groups (0-12 mM), although ton remained ~25% longer at each [Pi] for
NTG vs. t/t. Protein kinase-A (PKA) incubation reduced ton ~20% at each [Pi]
for NTG, but did not affect ton for t/t. The longer ton for NTG at saturating
MgATP suggests a longer lived MgADP myosin cross-bridge state when
cMyBP-C is present. The lower [MgATP]50 for NTG further suggests that
cMyBP-C elevates the nucleotide binding pocket affinity for MgATP in addi-
tion to MgADP. cMyBP-C phosphorylation by PKA may diminish this affinity
resulting in a shorter ton. These results support a functional role for cMyBP-C
slowing myosin kinetics, possibly through altered strain-dependent myosin
kinetics due to cMyBP-C supporting a stiffness of the thick filament or myofil-
ament lattice that is diminished with PKA phorphorylation of cMyBP-C.
2208-Plat
Activation of Cardiac Thin Filaments by N-Terminal Domains of Cardiac
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We have used double mixing stopped-flow fluorescence to study the effect of
the soluble N-terminal C1C2 domain of cMyBP-C on the activation of product
dissociation from myosin-S1-mdADP-Pi by native porcine thin filaments.
Product dissociation from cardiac actomyosin is an ordered process in which
phosphate dissociation is rate limiting (AM-mdADP-Pi / AM-mdADP /
AM) and can therefore be measured by the rate of mdADP dissociation.
Myosin-S1 was mixed with an equal concentration of the fluorescent ATP an-
alogue, mdATP, and held in a delay line 2 seconds for the nucleotide to bind
and be hydrolyzed (M þ mdATP/ M-mdATP4M-mdADP-Pi). The mix-
ture was subsequently mixed with native cardiac thin filaments, 1 mMMgATP,
1 mM EGTA and expressed mouse cMyBP-C domains C1C2. In control exper-
iments cMyBP-C was either replaced with NEM-S1 (a catalytically inactive
form of myosin-S1, modifed with N-ethylmaleimide, which binds to actin in
the presence of ATP), rigor myosin-S1 (in the absence of ATP) or 0.1 mM
CaCl2. Maximal activation of the rate of product dissociation by cMyBP-C
domains C1C2 is the same as observed with saturating rigor-myosin-S1 or
0.1 mM calcium and greater than observed with NEM-S1. These experiments
were done at physiological ionic strength (0.18 M KAc, 10 mM Mops, 2 mM
MgCl2, pH 7) to eliminate non specific ionic interaction that might occur at
lower ionic strength. Cardiac cMyBP-C domains C1C2 not only bind to actin
at a similar position to rigor myosin-S1 but substoichiometric concentrations
(1 cMyBP-C C1C2 per 7 actin subunits) are as effective as rigor myosin-S1
at activating cardiac thin filament in the absence of calcium.2209-Plat
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We have determined the effects of Myosin binding protein-C (MyBP-C) and its
domains on the microsecond time-scale rotational dynamics of actin, using
time-resolved phosphorescence anisotropy (TPA). MyBP-C is a multi-
domain thick filament-associated modulator of striated muscle contraction,
spanning the interfilament spacing to contact both myosin and actin. Cardiac
(c-) and slow skeletal (ss-) MyBP-C are known substrates for Protein kinase-
A (PKA), and phosphorylation of cMyBP-C alters contractile properties and
myofilament structure. To determine the effects of MyBP-C on actin’s micro-
second structural dynamics, we labeled actin at C374 with erythrosine iodoace-
tamide and performed TPA experiments. The interaction of all three MyBP-C
isoforms with actin increased the final anisotropy (rN) of the TPA decay in
a concentration-dependent manner, indicating restriction of the rotational am-
plitude of actin dynamics. While PKA phosphorylation had little effect on fast
skeletal (fs-) MyBP-C, phosphorylation of cMyBP-C and ssMyBP-C nearly
eliminated the effects of these proteins to restrict actin dynamics, despite no
change in binding affinity with phosphorylation. Skeletal MyBP-C (C1-C10)
affected actin anisotropy at lower concentrations than cMyBP-C (C0-C10),
suggesting that skeletal and cardiac N-terminal MyBP-C interactions with actin
have distinct properties. The effects of truncated cMyBP-C on actin anisotropy
determined that C-terminal domains are important for restricting rotational
dynamics, whereas N-terminal domains are important for regulating this effect.
These MyBP-C-induced changes in actin dynamics may play a role in the
known effects of MyBP-C on the functional actin-myosin interaction. This
work was funded by grants from NIH (F32 HL107039-01 to BAC and T32
AR007612 to DDT).
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proteins
Maegen Ackermann, Jane Valenti, AikateriniKontrogianni-Konstantopoulos.
University of Maryland, Baltimore, MD, USA.
Myosin Binding Protein-C (MyBP-C), a family of accessory proteins of stri-
ated muscles, contributes to the assembly and stabilization of thick filaments,
and regulates the formation of actomyosin cross-bridges. Three distinct
MyBP-C isoforms have been characterized; cardiac, slow skeletal and fast
skeletal. The slow isoform, sMyBP-C, consists of four alternatively spliced
forms, variants 1-4 (v1-4) that share common structures and sequences. Var-
iants 1-4 differ, however, in three regions; v1 and v2 contain a 25-residue long
insertion within the NH2-terminus, v3 carries an 18-amino acid long segment
within immunoglobulin domain C7 and v1 contains a unique COOH-terminus
consisting of 26 amino acids, while v4 does not possess any of these inser-
tions. Variants 1-4 are expressed in variable amounts among skeletal muscles,
exhibiting different topographies and potentially distinct functions. To date,
the regulatory mechanisms that modulate the activities of sMyBP-C are
unknown. Using an array of proteomic approaches, we show that sMyBP-C
comprises a family of phosphoproteins that are substrates for PKA and
PKC. The levels of phosphorylated skeletal MyBP-C proteins (i.e. slow and
fast) are increased in mouse dystrophic muscles, although their overall
amounts are decreased. In vitro binding and motility assays indicate that
sMyBP-C modulates the formation of actomyosin cross-bridges through inter-
actions with both actin and myosin. Importantly, the presence of the novel
insertions differentially affects the ability of sMyBP-C variants 1-4 to modu-
late cross-bridges formation. In summary, our studies are the first to show
that sMyBP-C comprises a subfamily of phosphoproteins that differentially
regulate actomyosin crossbridges.
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During recent years it has become increasingly evident that cardiac myosin
binding protein C (cMyBP-C) exerts an important role in regulation of
436a Tuesday, February 28, 2012sarcomere function with consequences for in vivo cardiac performance. The
functional role of cMyBP-C is tightly regulated by kinase-mediated phosphor-
ylation, of which protein kinase A (PKA)-mediated phosphorylation is impor-
tant during cardiac stress and exercise. To date, three serines have been
identified on which cMyBP-C can be phosphorylated in vivo, all of which
are located in the cardiac isoform specific M region, i.e. Ser273, Ser282 and
Ser 302. However, previous experiments have indicated that at least one
more phosphorylation site should exist in humans. The aim of the present study
was to identify the unknown phosphorylation site on human cMyBP-C.
cMyBP-C was semi-purified from human non-failing donor and end-stage fail-
ing cardiac tissue. Tandem mass spectrometry was used to identify phosphor-
ylation sites. Besides the already known Ser282 site, a phosphorylation site was
detected on Ser133 in donor tissue. For characterization of this site, a phospho-
specific antibody was developed. Levels of Ser133 phosphorylation are lower
in end-stage heart failure samples as well as in samples from hypertrophic
and dilated cardiomyopathy patients compared to donor. Initial experiments
suggest that unlike the three previously known phosphorylation sites, Ser133
is not phosphorylated by PKA.
In conclusion, we identified a fourth phosphorylation site (Ser133) in human
cMyBP-C, which is present in the Pro-Ala rich region that links the C0 and
C1 domains. This site is less phosphorylated in various cardiac pathologies
and does not seem to be a target of PKA.
Supported by the 7th Framework Program of the European Union (‘‘BIG-
HEART,’’ grant agreement 241577).
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Cardiac myosin binding protein-C (cMyBP-C), a sarcomeric protein with 11
domains- C0-C10, binds myosin LMM via its C-terminus, while its N-terminus
binds both myosin S2 and actin. These N-terminal interactions can be attenu-
ated by phosphorylation of serines within the C1-C2 linker. In vivo, cMyBP-
C exists in a range of phosphorylation states, which may alter its regulation
of actomyosin. Therefore, N-terminal fragments (C0-C3) of cMyBP-C were
bacterially expressed with one or more phosphorylatable serines (S273,
S282, S302) mutated to either alanines to mimic dephosphorylation or
aspartic acids as phosphomimetics. Using C0-C3 fragments that were effec-
tively mono-, di- or tri-phosphorylated, we characterized how the extent of
cMyBP-C phosphorylation modulated the the force:velocity relationship gener-
ated by a small ensemble (~8 motors) of skeletal muscle myosin in the load-
clamped laser trap assay. Mono-phosphorylated C0-C3 inhibited unloaded
velocity by 70% as did unphosphorylated C0-C3, while di- and tri-
phosphorylated constructs were indistinguishable and less inhibitory (30%).
Maximal force was unaffected by the extent of phosphorylation. Thus, the
un- and mono-phosphorylated C0-C3 constructs depressed the force-velocity
relationship, which was well fitted by a modified Hill equation containing an
assumed viscous load due to C0-C3 binding to actin (Weith et al., 2011). In
addition, both un- and mono- phosphorylated C0-C3 reduced peak power by
~40%, while neither di- nor tri-phosphorylated C0-C3 had any effect on peak
power. cMyBP-C phosphorylation appears to modulate cMyBP-C’s inhibition
of actomyosin power generation in an ‘‘on/off’’ manner.
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Enhanced cardiac contractility results from phosphorylation within the
cMyBP-C motif domain by affecting the interaction of cMyBP-C’s N-terminus
with actin and/or myosin. We investigated whether motif (i.e. C1C2 linker)
phosphorylation alters its structural conformation by characterizing the force-
extension behavior of expressed N-terminal cMyBP-C fragments (i.e.C0C3)
that contain the motif using atomic force spectroscopy. Proteins were adsorbed
onto glass slides, bound non-specifically to SiNi AFM probes, and stretched at
700nm/s. Force-extension traces showed the characteristic sawtooth shape of
unfolding immunoglobulin domains, and were well fitted by the wormlike
chain model. The model fits produced a median persistence length of 0.36nm
and an average C0C3 contour length of 71.5nm, suggesting that the motif is dis-ordered and freely extensible when unphosphorylated. PKA phosphorylation
did not change immunoglobulin unfolding force or persistence length but de-
creased the contour length by 27nm, suggesting that the motif assumed a folded
configuration that is stable under load. This was investigated further by varying
the extent of phosphorylation using phosphomimetic mutants, in which serines
273, 282, and 302 were replaced with different combinations of alanines or as-
partic acids in order to mimic the unphosphorylated and phosphorylated states
respectively. While substitution with all alanines or all aspartic acids produced
similar results to the control and PKA treated fragments respectively, phos-
phorylation at only one or two sites did not reduce contour length significantly.
This implies that phosphorylation at all three sites is required for motif folding
to be stable under load, while partial phosphorylation may result in a fold which
is readily extended at low force. In conclusion, cMyBP-C phosphorylation
could modulate the cMyBP-C’s N-terminal domain interactions with actin
and/or myosin by folding the motif in such a way that binding sites for actin
and/or myosin are hidden.
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Titin is a giant protein that functions as a molecular spring and contributes to
the passive diastolic stiffness of the left ventricle (LV). Titin’s spring region
consists of three sequence elements: the tandem Ig, the N2B and the PEVK el-
ements. Mouse models exist in which either of the latter two elements (N2B
KO, PEVK KO) has been deleted, but considering that these elements are
also likely to play roles in signaling, we made a model in which we deleted
2/3 of the proximal tandem Ig element (IGKO), a region that is not known to
contain signaling functions. Homozygous KO mice survive to adulthood and
are fertile with no change in LV Weight to Body Weight (LVW/BW) ratio
(3.6750.07mg/g WT vs 3.5150.04mg/g IgKO). A custom titin exon microar-
ray confirmed the deletion of the expected exons with no other changes. Gel
electrophoresis showed that the IGKO expresses an 88kDa smaller titin isoform
but no other changes in isoform expression. Immuno-electron microscopy indi-
cates that the remaining spring elements extend to a higher degree than in WT
myocardium. Mechanical measurements in cardiomyocytes (see also poster by
Methawasin) and myofibers show that the deletion increases passive stiffness in
titin in a sarcomere length dependence manner, without adaptations in the pas-
sive stiffness of the extracellular matrix. Initial isolated intact heart data and
in-vivo pressure volume measurement suggest that the IGKO has increased
stiffness in-vivo. Further phenotypic characterization is currently underway.
In summary, shortening the proximal tandem Ig element of titin produces a
diastolic stiffness phenotype.Platform: Mitochondria in Cell Life & Death
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Tubulin has been recently identified as a powerful regulator of voltage depen-
dent anion channel (VDAC). Dimeric tubulin induces reversible blockage of
VDAC reconstituted into planar lipid membranes and blocks the flux of
ATP/ADP across the mitochondrial outer membrane. Here we show that phos-
phorylation of VDAC by cytosolic kinases protein kinase A (PKA) and glyco-
gen synthase kinase-3b (GSK3b) increases the on-rate of tubulin binding by
orders of magnitude, but only for tubulin at the cis (or cytosolic) side of the
membrane. This and the fact that the basic properties of VDAC, such as
single-channel conductance and selectivity, remained unaltered by phosphory-
lation allowed us to suggest the phosphorylation regions positioned on the
cytosolic loops of VDAC and establish channel orientation in our reconstitution
experiments. Experiments on human hepatoma cells HepG2 are in agreement
with our findings that phosphorylation state of VDAC determines its blockage
by tubulin. When HepG2 cells were treated with the microtubule-destabilizing
